Ciconia Bioventures announced its establishment as a joint venture, or JV, company based on a master agreement signed on April 22 by Takeda Pharmaceutical (TAK), Astellas Pharma (ALPMY), and Sumitomo Mitsui Banking Corporation (SMFG). Ciconia covers the entire process from early drug discovery research to establishment of biotech startups, with the aim of translating innovative technologies and drug discovery programs originating in Japan into clinical applications.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TAK: